Addition of extended-release niacin to statin therapy: effects on atherosclerotic progression
- PMID: 20048522
- DOI: 10.3810/psm.2009.06.1722
Addition of extended-release niacin to statin therapy: effects on atherosclerotic progression
Comment on
-
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.Circulation. 2004 Dec 7;110(23):3512-7. doi: 10.1161/01.CIR.0000148955.19792.8D. Epub 2004 Nov 10. Circulation. 2004. PMID: 15537681 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources